These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

434 related items for PubMed ID: 2499519

  • 1. Different dopaminergic control of plasma luteinizing hormone, follicle-stimulating hormone and prolactin in ovulatory and postmenopausal women: effect of ovariectomy.
    De Leo V, Petraglia F, Bruno MG, Lanzetta D, Inaudi P, D'Antona N.
    Gynecol Obstet Invest; 1989; 27(2):94-8. PubMed ID: 2499519
    [Abstract] [Full Text] [Related]

  • 2. Pituitary-ovarian relationships preceding the menopause. I. A cross-sectional study of serum follice-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels.
    Reyes FI, Winter JS, Faiman C.
    Am J Obstet Gynecol; 1977 Nov 01; 129(5):557-64. PubMed ID: 910845
    [Abstract] [Full Text] [Related]

  • 3. [Possible mechanisms of the interaction between gonadotropins and prolactin in an experimental hyperprolactinemia model].
    Tresguerres JA, Esquifino AI.
    Acta Physiol Lat Am; 1983 Nov 01; 33(3):257-74. PubMed ID: 6424409
    [Abstract] [Full Text] [Related]

  • 4. Metoclopramide effect on serum prolactin LH and FSH in patients with polycystic ovary syndrome.
    Prelević GM, Würzburger MI, Perić LA.
    J Endocrinol Invest; 1988 Apr 01; 11(4):255-9. PubMed ID: 3137253
    [Abstract] [Full Text] [Related]

  • 5. Acute dopaminergic blockade augments the naloxone-induced LH rise in estrogen-treated postmenopausal women.
    Parra A, Barrón J, Marín VA, Coutiño B, Belmont J, Coria I.
    Maturitas; 1997 May 01; 27(1):91-9. PubMed ID: 9158083
    [Abstract] [Full Text] [Related]

  • 6. Dopaminergic control of gonadotrophin secretion in normal women and in patients with pathological hyperprolactinaemia.
    Ho KY, Smythe GA, Lazarus L.
    Clin Endocrinol (Oxf); 1984 Jan 01; 20(1):53-63. PubMed ID: 6420095
    [Abstract] [Full Text] [Related]

  • 7. [Effects of bromocriptine and dopamine on pituitary hormone secretion in women].
    Masaoka K, Hosoya N, Mori T, Watanabe H, Ohkura T, Kumasaka T.
    Nihon Sanka Fujinka Gakkai Zasshi; 1982 Dec 01; 34(12):2155-62. PubMed ID: 6818310
    [Abstract] [Full Text] [Related]

  • 8. Evidence for increased dopaminergic and opioid activity in patients with hypothalamic hypogonadotropic amenorrhea.
    Quigley ME, Sheehan KL, Casper RF, Yen SS.
    J Clin Endocrinol Metab; 1980 May 01; 50(5):949-54. PubMed ID: 6246138
    [Abstract] [Full Text] [Related]

  • 9. Temporal relations between plasma concentrations of luteinizing hormone, follicle-stimulating hormone, estradiol-17beta, progesterone, prolactin, and alpha-melanocyte-stimulating hormone during the follicular, ovulatory, and early luteal phase in the bitch.
    de Gier J, Kooistra HS, Djajadiningrat-Laanen SC, Dieleman SJ, Okkens AC.
    Theriogenology; 2006 Apr 15; 65(7):1346-59. PubMed ID: 16197989
    [Abstract] [Full Text] [Related]

  • 10. Prolactin and gonadotrophin dynamics in response to antagonists of LHRH and dopamine in ovariectomized rhesus monkeys: a dissection of their common secretion.
    Geisthoevel F, Arana JB, Balmaceda JP, Rojas FJ, Asch RH.
    Hum Reprod; 1988 Jul 15; 3(5):591-5. PubMed ID: 3139699
    [Abstract] [Full Text] [Related]

  • 11. [A longitudinal study on the prognosis of ovulatory disturbance in teenage patients with high LH and normal FSH serum levels].
    Kimura K, Minakami H, Tamada T.
    Nihon Naibunpi Gakkai Zasshi; 1988 Oct 20; 64(10):1088-101. PubMed ID: 3145220
    [Abstract] [Full Text] [Related]

  • 12. Serotonin antagonist-induced lowering of prolactin secretion does not affect the pattern of pulsatile secretion of follicle-stimulating hormone and luteinizing hormone in the bitch.
    Beijerink NJ, Kooistra HS, Dieleman SJ, Okkens AC.
    Reproduction; 2004 Aug 20; 128(2):181-8. PubMed ID: 15280557
    [Abstract] [Full Text] [Related]

  • 13. Effects of streptozotocin-induced diabetes on neuroendocrine responses to ovariectomy and estrogen replacement in female rats.
    Steger RW, Kienast SG, Pillai S, Rabe M.
    Neuroendocrinology; 1993 Mar 20; 57(3):525-31. PubMed ID: 8321421
    [Abstract] [Full Text] [Related]

  • 14. Depressed follicle-stimulating hormone, luteinizing hormone, and prolactin responses to the luteinizing hormone-releasing hormone, thyrotropin-releasing hormone, and metoclopramide test in endurance runners in the hard-training season.
    Ronkainen H.
    Fertil Steril; 1985 Dec 20; 44(6):755-9. PubMed ID: 3935485
    [Abstract] [Full Text] [Related]

  • 15. Influence of dopamine on the altered release of prolactin, luteinizing hormone, and follicle-stimulating hormone induced by interleukin-2 in vitro.
    Karanth S, Marubayashi U, McCann SM.
    Neuroendocrinology; 1992 Dec 20; 56(6):871-80. PubMed ID: 1369597
    [Abstract] [Full Text] [Related]

  • 16. Effects of dopamine infusion on pituitary hormone secretion in humans.
    Leblanc H, Lachelin GC, Abu-Fadil S, Yen SS.
    J Clin Endocrinol Metab; 1976 Sep 20; 43(3):668-74. PubMed ID: 956350
    [Abstract] [Full Text] [Related]

  • 17. Effects of the gonadotropin-releasing hormone associated peptides (GAP) on the release of luteinizing hormone (LH), follicle stimulating hormone (FSH) and prolactin (PRL) in vivo.
    Yu WH, Arisawa M, Millar RP, McCann SM.
    Peptides; 1989 Sep 20; 10(6):1133-8. PubMed ID: 2516311
    [Abstract] [Full Text] [Related]

  • 18. Posterior pituitary involvement in the control of luteinizing hormone and prolactin secretion during the estrous cycle.
    Froehlich JC, Ben-Jonathan N.
    Endocrinology; 1984 Apr 20; 114(4):1059-64. PubMed ID: 6423366
    [Abstract] [Full Text] [Related]

  • 19. Estrogen modulates the action of nitric oxide in the medial preoptic area on luteinizing hormone and prolactin secretion.
    Moreno AS, Franci CR.
    Life Sci; 2004 Mar 05; 74(16):2049-59. PubMed ID: 14967199
    [Abstract] [Full Text] [Related]

  • 20. Catecholamines and pituitary function. I. Effects of catecholamine synthesis inhibition and subsequent catecholamine infusion on gonadotropin and prolactin serum levels in normal cycling women and in women with hyperprolactinemic amenorrhea.
    Nicoletti I, Filipponi P, Sfrappini M, Fedeli L, Petrelli S, Gregorini G, Santeusanio F, Brunetti P.
    Horm Res; 1984 Mar 05; 19(3):158-70. PubMed ID: 6425187
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.